Onderneming Fennec Pharmaceuticals Inc Other OTC
Aandelen
CA31447P1009
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Sodium Thiosulfate
100,0
%
| 2 | 100,0 % | 29 | 100,0 % | +1.335,37% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 29 | 100,0 % | +1.335,37% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 07-07-09 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07-07-09 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 25-04-14 |
Mark Gowland
AUD | Comptroller/Controller/Auditor | 52 | 01-11-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 25-08-11 |
Khalid Islam
CHM | Chairman | 67 | 25-04-14 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07-07-09 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 25-04-14 |
Marco Brughera
BRD | Director/Board Member | 70 | 10-08-16 |
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 07-07-09 |
Jodi Cook
BRD | Director/Board Member | 56 | 24-09-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 27 099 908 | 22 954 258 ( 84,70 %) | 0 | 84,70 % |
Bedrijfsgegevens
Fennec Pharmaceuticals, Inc.
Research Triangle Park 68 T.W. Alexander Drive
27709, Durham
+919 636 4530
http://www.fennecpharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |